RB
Rajeshkumar Babulal
About Rajeshkumar Babulal
Data last updated:
Rajeshkumar Babulal is a Director at Bio-Clinaarc Private Limited (since 2024) and Director at Lybra Clinical Research Private Limited (since 2022). The companies operate in Pharma and Research & Development. The 2 current companies with reported revenue have a combined latest revenue of ₹1.07 Cr; the largest is Bio-Clinaarc Private Limited at ₹61.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bio-Clinaarc Private Limited U72900MH2015PTC268917 | Director | 01 Aug 2024 | 2015 | ₹61.2 Lakh (FY 2025) | Active |
 Lybra Clinical Research Private Limited U73100PN2022PTC213748 | Director | 05 Aug 2022 | 2022 | ₹45.7 Lakh (FY 2025) | Active |
Board colleagues of Rajeshkumar Babulal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anilkumar Laxman Meshram | 07282121 | Bio-Clinaarc Private Limited | Director |
| Suman Rajesh Meshram | 07282138 | Bio-Clinaarc Private Limited | Director |
| Dimple Kumari | 09697883 | Lybra Clinical Research Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajeshkumar Babulal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajeshkumar Babulal
Rajeshkumar Babulal currently holds 2 directorships: Bio-Clinaarc Private Limited (Director, since 01 Aug 2024, revenue ₹61.2 Lakh (FY 2025)); Lybra Clinical Research Private Limited (Director, since 05 Aug 2022, revenue ₹45.7 Lakh (FY 2025)).
Rajeshkumar Babulal was first appointed on 05 Aug 2022 as Director at Lybra Clinical Research Private Limited. The most recent appointment on record is 01 Aug 2024 at Bio-Clinaarc Private Limited.
The 2 current companies of Rajeshkumar Babulal that report revenue have a combined latest revenue of ₹1.07 Cr: Bio-Clinaarc Private Limited ₹61.2 Lakh (FY 2025); Lybra Clinical Research Private Limited ₹45.7 Lakh (FY 2025).
The current boards of Rajeshkumar Babulal's companies include Anilkumar Laxman Meshram (Bio-Clinaarc Private Limited), Suman Rajesh Meshram (Bio-Clinaarc Private Limited), Dimple Kumari (Lybra Clinical Research Private Limited).